Ceryvyn Therapeutics Limited
Important Dates
Ceryvyn Therapeutics Ltd.'s next confirmed earnings release is scheduled for February 23, 2027.
| Earnings Date | 2/23/2027 |
Share Statistics
As of December 31, 2024, Ceryvyn Therapeutics Ltd. has 412.32M shares outstanding.
| Shares Outstanding | 412.32M |
Financial Position
As of December 31, 2024, Ceryvyn Therapeutics Ltd. maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.57 |
| Quick Ratio | 1.52 |
| Debt / Equity | -93.21 |
Stock Price Statistics
USDAs of the close on July 14, 2026, Ceryvyn Therapeutics Ltd.'s stock has declined approximately 99.37% over the past 52 weeks. The 50-day moving average sits at 0.03, while the 200-day moving average is 1.39.
| 52-Week Price Change | -99.37% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 1.39 |
Balance Sheet
USDAs of December 31, 2024, Ceryvyn Therapeutics Ltd. holds 131.33M in cash and equivalents against 156.54M in total debt, resulting in a net debt position of 25.18M. Total book value stands at -167.95M, with working capital of 52.14M providing operational flexibility.
| Cash & Cash Equivalents | 131.33M |
| Total Debt | 156.54M |
| Net Debt | 25.18M |
| Equity (Book Value) | -167.95M |
| Book Value Per Share | -0.41 |
| Working Capital | 52.14M |
Cash Flow
USDThese figures cover the twelve months ended December 31, 2024.
| Capital Expenditures | -12,941.82 |
Stock Splits
Ceryvyn Therapeutics Ltd.'s most recent stock split took place on June 14, 2024.
| Last Split Date | 6/14/2024 |